Cargando…
Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice
Asthma phenotyping and endotyping are constantly evolving. Currently, several biologic agents have been developed towards a personalized approach to asthma management. This review will focus on different eosinophilic phenotypes and Th2-associated endotypes with eosinophilic inflammation. Additionall...
Autores principales: | Porpodis, Konstantinos, Tsiouprou, Ioanna, Apostolopoulos, Apostolos, Ntontsi, Polyxeni, Fouka, Evangelia, Papakosta, Despoina, Vliagoftis, Harissios, Domvri, Kalliopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316404/ https://www.ncbi.nlm.nih.gov/pubmed/35887589 http://dx.doi.org/10.3390/jpm12071093 |
Ejemplares similares
-
Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2023) -
Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022) -
Recent insights in the role of biomarkers in severe asthma management
por: Fouka, Evangelia, et al.
Publicado: (2022) -
Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
por: Domvri, Kalliopi, et al.
Publicado: (2023) -
Cytokine gene polymorphisms in Greek patients with severe asthma
por: Papakosta, Despina, et al.
Publicado: (2015)